Biotek-snakken — December 2025
-
Mads83 og LP90 - ja begge er spændende, og selv har jeg undret mig over, at der ikke skrives om dem her på PI. Når du nævner Curasigth kunne du også tageFluoguide med. Begge har en MV på ca 400 Mille. Kæmpe potentiale og både større og mere “sikkert” end flere af dem der normalt skrives om her på PI
-
PILA PHARMA ANNOUNCES PRE-CLINICAL OBESITY AND AMYLIN
SPECIALIST PROFESSOR THOMAS LUTZ TO JOIN AS SCIENTIFIC
ADVISER https://cdn.bequoted.com/media/1/ea30b14e-f4ed-474a-b0f7-f27f3cc5d379/PILA_PHARMA_Pressrelease_2025-12-04.pdf -
Dårligt nyt fra Cantargia. https://cantargia.com/en/press-releases/cantargia-provides-update-on-overall-survival-data-from-trifour
-
Godmorgen
-
PARETO SER FÖRSTÄRKT FÖRHOPPNING BI-1808 NÅR MARKNAD
PARETO SER FÖRSTÄRKT FÖRHOPPNING BI-1808 NÅR MARKNAD | Placera.se
PARETO SER FÖRSTÄRKT FÖRHOPPNING BI-1808 NÅR MARKNAD
placera.se (www.placera.se)
"Pareto upprepar sin köprekommendation för Bioinvent med en riktkurs på 134 kronor."
-
BioInvent to Present Updated Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025
-
Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025
Company to host video conference call and webcast at 8:00 a.m. ET on Monday, December 8, 2025 WATERTOWN, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will announce results from the BroADen Phase 1b clinical trial evaluating KT-621, its oral STAT6 degrader, in patients with moderate to severe atopic dermatitis (AD) on Monday,
Yahoo Finance (finance.yahoo.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind